• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    US Ureteral Stents Market

    ID: MRFR/MED/13956-HCR
    100 Pages
    Rahul Gotadki
    October 2025

    US Ureteral Stents Market Research Report By Type (Double Pigtail Ureteral Stent, Others), By Material (Metallic Stents, Polymers Stents, others), By Treatment (Kidney Stones, Kidney Transplant, Others) and By End User (Hospitals, Nephrological Centers, Ambulatory Surgical Centers) - Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    US Ureteral Stents Market Infographic
    Purchase Options

    US Ureteral Stents Market Summary

    The United States Ureteral Stents market is projected to grow from 130 USD Million in 2024 to 240 USD Million by 2035.

    Key Market Trends & Highlights

    US Ureteral Stents Key Trends and Highlights

    • The market is expected to experience a compound annual growth rate (CAGR) of 5.73% from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 240 USD Million, indicating robust growth potential.
    • In 2024, the market is valued at 130 USD Million, reflecting a solid foundation for future expansion.
    • Growing adoption of advanced medical technologies due to increasing prevalence of urinary tract disorders is a major market driver.

    Market Size & Forecast

    2024 Market Size 130 (USD Million)
    2035 Market Size 240 (USD Million)
    CAGR (2025-2035) 5.73%

    Major Players

    Teleflex, Auris Health, C.R. Bard, Smiths Medical, B. Braun, Boston Scientific, Coloplast, Medtronic, MediFlex, UroGen Pharma, Stryker, Richard Wolf, Cook Medical, Johnson and Johnson, CooperSurgical

    US Ureteral Stents Market Trends

    The US Ureteral Stents Market is experiencing significant trends driven by advancements in medical technology and increasing awareness of urinary tract disorders. One of the key market drivers is the rising prevalence of kidney stones and urinary tract infections, which stimulate the demand for ureteral stenting procedures. Improved healthcare infrastructure and technological innovations in stent design, such as biocompatible materials and drug-eluting stents, enhance patient outcomes and safety, thus driving market growth.

    Opportunities in this market are primarily rooted in the increasing adoption of minimally invasive surgical techniques. As healthcare providers seek to improve patient recovery times and reduce complications associated with traditional surgery, ureteral stents have gained acceptance. Additionally, the development of next-generation stents that offer better comfort and reduced chances of encrustation is an avenue that can be explored further.

    In recent times, there has also been a shift towards patient-centric care, where the focus is not only on treating conditions but also on improving the overall patient experience during treatment. The US healthcare system emphasizes shared decision-making and patient education regarding procedures, which influences the demand for ureteral stents favorably. Moreover, regulatory bodies such as the FDA play a crucial role in ensuring the safety and efficacy of medical devices, further shaping market trends as they approve new and innovative stent solutions.

    Overall, the US Ureteral Stents Market is evolving in response to healthcare trends that prioritize technological advancement, increased procedural volume, and improved patient care pathways.

    Market Segment Insights

    Ureteral Stents Market Type Insights

    The US Ureteral Stents Market is structured into various types, serving diverse clinical needs and applications, with notable segments including Double Pigtail Ureteral Stent and others. The Double Pigtail Ureteral Stent, recognized for its unique design featuring coiled ends that help secure the stent in place, plays a crucial role in managing urinary obstructions and ensuring proper urinary drainage. This type of stent has gained popularity due to its effectiveness in various procedures, such as ureteroscopy, as well as its lower risk of complications compared to traditional stents.

    On the other hand, the segment categorized as 'Others' encompasses a range of alternative stent designs and materials, which cater to specific patient requirements or unique medical conditions. This diversity allows for tailoring patient management strategies, enhancing treatment effectiveness while also minimizing discomfort. The demand for both segments is primarily driven by the increasing prevalence of urological conditions in the United States, leading to higher revascularization rates and a push for innovative solutions in urinary tract management.

    The awareness of stent-related complications further fuels growth in the market, as healthcare professionals increasingly opt for designs that mitigate risks associated with prolonged use. Factors such as technological advancements in stent materials and designs, alongside the growing geriatric population susceptible to urological disorders, offer numerous growth opportunities for the US Ureteral Stents Market. Specifically, advancements in biocompatible materials have shown the potential to enhance patient comfort and stent lifespan, fostering a favorable outlook for type-specific innovations.

    The overall market growth and segmentation dynamics are reflective of ongoing trends, which emphasize patient-centric solutions, safety, and efficacy. Continued Research and Development efforts in both Double Pigtail Ureteral Stent and other designs highlight the commitment to improving clinical outcomes and patient quality of life in the US healthcare landscape.

    Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

    Ureteral Stents Market Material Insights

    The US Ureteral Stents Market is significantly influenced by the material segment, which includes categories such as Metallic Stents, Polymers Stents, and others. In recent years, the emphasis on biocompatible materials has gained traction, as it enhances patient comfort and minimizes the risk of complications. Metallic Stents are known for their strength, durability, and ability to provide consistent drainage, making them a preferred choice for long-term usage in patients with obstructions.

    On the other hand, Polymers Stents have emerged as an important option due to their flexibility and ease of implantation, catering to varied patient needs. The versatility of both material types supports their usage in different clinical scenarios, contributing to the overall growth of the US Ureteral Stents Market. The dynamics of innovation and Research and Development in these materials further drive advancements, allowing for enhanced stent designs that can improve patient outcomes.

    As the healthcare landscape evolves, these segments are pivotal in addressing the complexities of urinary tract obstructions while ensuring patient safety and satisfaction, reflecting ongoing trends and demands in the medical device industry.

    Ureteral Stents Market Treatment Insights

    The Treatment segment of the US Ureteral Stents Market is pivotal in addressing various urinary tract conditions. This segment primarily focuses on three key areas: Kidney Stones, Kidney Transplant, and other related conditions. Kidney Stones treatment has been prominent due to the high prevalence of renal calculi in the US population, with millions affected annually, thereby necessitating effective solutions. Kidney Transplant procedures also rely heavily on ureteral stenting to ensure proper urine flow post-surgery, significantly impacting patient recovery.

    Additionally, other conditions such as ureteral strictures and tumors represent growing areas of concern, where stents play a critical role in management. The increasing awareness and advancements in minimally invasive urological procedures are contributing factors to the market growth, as healthcare providers seek to optimize patient outcomes while reducing recovery times. Collectively, these elements underscore the significance of the Treatment segment in enhancing healthcare delivery associated with the US Ureteral Stents Market.

    Ureteral Stents Market End User Insights

    The US Ureteral Stents Market encompasses a diverse range of End User settings, reflecting the multifaceted application of ureteral stents in the healthcare landscape. Hospitals represent a crucial segment, often being the primary locations for advanced urological procedures, where the demand for ureteral stents is significant due to the higher surgical volumes and complex case management typically encountered. Nephrological Centers also play a vital role, as they specialize in kidney-related disorders and require specialized ureteral stents for patient care and management of urinary obstructions.

    Ambulatory Surgical Centers are becoming increasingly important as well, driven by the trend towards outpatient procedures, which encourages efficient stent placements and faster patient recovery times. Overall, the End User segment reflects the evolving dynamics of healthcare delivery in the US, driven by the need for improved patient outcomes, advancements in medical technology, and the growing prevalence of urinary conditions that necessitate the use of ureteral stents in various healthcare settings.

    Get more detailed insights about US Ureteral Stents Market

    Key Players and Competitive Insights

    The US Ureteral Stents Market is characterized by intense competition, driven by the continuous advancements in medical technology and an increasing prevalence of kidney-related disorders. The market includes a variety of stakeholders such as manufacturers, healthcare professionals, and patients, all of whom play significant roles in the growth and development of ureteral stents. As a pivotal area within the broader urology market, ureteral stents serve crucial functions in managing various conditions, including urinary obstructions, and the choice of stents can greatly impact patient outcomes.

    Companies within this sector continually strive to innovate and enhance the performance of their products, often working in collaboration with healthcare providers to optimize surgical procedures and improve patient care. The competitive landscape is further influenced by regulatory challenges, evolving reimbursement policies, and increasing awareness regarding the importance of effective ureteral stenting.

    Teleflex stands out in the US Ureteral Stents Market due to its robust commitment to innovation and quality. The company has established a strong market presence by offering a diverse range of ureteral stenting solutions that emphasize safety, efficiency, and reliability. Teleflex focuses on enhancing its product portfolio through ongoing research and development efforts, ensuring that its stents meet the evolving needs of healthcare professionals and patients alike. The company's emphasis on strong customer relationships and its reputation for high-quality products position it advantageously within the market.

    Additionally, proactive marketing strategies and an extensive distribution network allow Teleflex to effectively reach key healthcare providers, ensuring that its products are widely accessible in various clinical settings across the United States.

    Auris Health is another key player in the US Ureteral Stents Market, known for its innovative approaches to minimally invasive surgical techniques. The company's strong focus on advanced technologies has positioned it favorably, allowing it to provide state-of-the-art ureteral stenting solutions. Auris Health's products emphasize precision and ease of use, which are crucial in urological procedures. The company's growth is further bolstered by strategic mergers and acquisitions, which have expanded its market presence and enhanced its offerings. With a commitment to improving patient outcomes and clinician efficiency, Auris Health continues to push the boundaries of technology in urology.

    Its extensive product line, combined with an agile approach to meeting market demands, enables Auris Health to maintain a competitive edge in the US ureteral stents arena.

    Key Companies in the US Ureteral Stents Market market include

    Industry Developments

    Recent developments in the US Ureteral Stents Market have witnessed ongoing innovations and strategic activities by leading companies. Teleflex recently announced advancements in its urology product line, emphasizing improved patient outcomes and enhanced usability. Notably, in September 2023, Boston Scientific launched a new ureteral stent that is designed for easier placement, responding to the growing demand for minimally invasive options. Medtronic has focused on expanding its presence through a series of collaborations and R&D efforts targeting better stent materials for improved biocompatibility.

    As for mergers and acquisitions, C.R. Bard, now a part of BD, has been strategically consolidating its product offerings, with BD's acquisition completed in December 2017 still influencing market dynamics. Moreover, UroGen Pharma has been gaining attention for its innovative drug-device combinations in urinary tract treatments, enhancing its market valuation. In the last couple of years, significant growth has been noted in the Ureteral Stents Market, with increasing adoption rates attributed to rising incidences of urological disorders and advancements in healthcare technologies.

    The landscape remains competitive, with companies like Smiths Medical and CooperSurgical continuously evolving their product strategies to align with growing patient needs.

    Market Segmentation

    Ureteral Stents Market Type Outlook

    • Double Pigtail Ureteral Stent
    • Others

    Ureteral Stents Market End User Outlook

    • Hospitals
    • Nephrological Centers
    • Ambulatory Surgical Centers

    Ureteral Stents Market Material Outlook

    • Metallic Stents
    • Polymers Stents
    • others

    Ureteral Stents Market Treatment Outlook

    • Kidney Stones
    • Kidney Transplant
    • Others

    Report Scope

    Report Attribute/Metric Source: Details
    MARKET SIZE 2018 122.82(USD Million)
    MARKET SIZE 2024 130.0(USD Million)
    MARKET SIZE 2035 240.0(USD Million)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 5.732% (2025 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    MARKET FORECAST PERIOD 2025 - 2035
    HISTORICAL DATA 2019 - 2024
    MARKET FORECAST UNITS USD Million
    KEY COMPANIES PROFILED Teleflex, Auris Health, C.R. Bard, Smiths Medical, B. Braun, Boston Scientific, Coloplast, Medtronic, MediFlex, UroGen Pharma, Stryker, Richard Wolf, Cook Medical, Johnson and Johnson, CooperSurgical
    SEGMENTS COVERED Type, Material, Treatment, End User
    KEY MARKET OPPORTUNITIES Rising prevalence of kidney disorders, Technological advancements in stent design, Increasing aging population, Growing adoption of minimally invasive procedures, Expanding outpatient surgical centers
    KEY MARKET DYNAMICS Increasing prevalence of urinary disorders, Technological advancements in stent design, Rising geriatric population, Growing awareness and education, Expanding healthcare infrastructure
    COUNTRIES COVERED US

    FAQs

    What is the expected market size of the US Ureteral Stents Market in 2024?

    The US Ureteral Stents Market is expected to be valued at 130.0 million USD in 2024.

    What is the projected market size of the US Ureteral Stents Market by 2035?

    By 2035, the market is projected to reach 240.0 million USD.

    What is the expected CAGR for the US Ureteral Stents Market from 2025 to 2035?

    The expected CAGR for the US Ureteral Stents Market from 2025 to 2035 is 5.732%.

    What are the key types of ureteral stents in the market?

    The major types of ureteral stents include Double Pigtail Ureteral Stent and other types.

    What is the market size for Double Pigtail Ureteral Stents in 2024?

    The market for Double Pigtail Ureteral Stents is valued at 75.0 million USD in 2024.

    What is the anticipated market size for other types of ureteral stents in 2035?

    The anticipated market size for other types of ureteral stents is projected to be 100.0 million USD by 2035.

    Who are the major players in the US Ureteral Stents Market?

    Key players in the market include Teleflex, Auris Health, C.R. Bard, and Boston Scientific among others.

    What growth opportunities exist in the US Ureteral Stents Market?

    Emerging trends and the increasing prevalence of urological conditions present significant growth opportunities.

    How is the competitive landscape of the US Ureteral Stents Market structured?

    The competitive landscape is diverse, with major companies vying for market share in a growing sector.

    What are the key challenges facing the US Ureteral Stents Market?

    Challenges include regulatory hurdles and the need for innovation in stent technology.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials